Virander S Chauhan
Overview
Explore the profile of Virander S Chauhan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
1485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yadav N, Chauhan V
Adv Colloid Interface Sci
. 2024 Sep;
333:103282.
PMID: 39276418
In recent years, multidrug-resistant pathogenic microorganisms (MDROs) have emerged as a severe threat to human health, exhibiting robust resistance to traditional antibiotics. This has created a formidable challenge in modern...
2.
Barrett J, Silk S, Mkindi C, Kwiatkowska K, Hou M, Lias A, et al.
Front Immunol
. 2024 Feb;
14:1193079.
PMID: 38299155
We have previously reported primary endpoints of a clinical trial testing two vaccine platforms for the delivery of malaria DBPRII: viral vectors (ChAd63, MVA), and protein/adjuvant (PvDBPII with 50µg Matrix-M™...
3.
Martinez F, White M, Guillotte-Blisnick M, Huon C, Boucharlat A, Agou F, et al.
NPJ Vaccines
. 2024 Jan;
9(1):10.
PMID: 38184681
The receptor-binding domain, region II, of the Plasmodium vivax Duffy binding protein (PvDBPII) binds the Duffy antigen on the reticulocyte surface to mediate invasion. A heterologous vaccine challenge trial recently...
4.
Martinez F, Guillotte-Blisnick M, Huon C, England P, Popovici J, Laude H, et al.
Sci Rep
. 2023 Aug;
13(1):13904.
PMID: 37626150
The invasion of reticulocytes by Plasmodium vivax merozoites is dependent on the interaction of the Plasmodium vivax Duffy Binding Protein (PvDBP) with the Duffy antigen receptor for chemokines (DARC). The...
5.
Hou M, Barrett J, Themistocleous Y, Rawlinson T, Diouf A, Martinez F, et al.
Sci Transl Med
. 2023 Jul;
15(704):eadf1782.
PMID: 37437014
There are no licensed vaccines against . We conducted two phase 1/2a clinical trials to assess two vaccines targeting Duffy-binding protein region II (PvDBPII). Recombinant viral vaccines using chimpanzee adenovirus...
6.
Yadav N, Kumar U, Roopmani P, Krishnan U, Sethuraman S, Chauhan M, et al.
ACS Appl Mater Interfaces
. 2023 Mar;
15(9):12609.
PMID: 36890696
No abstract available.
7.
Yadav N, Kumar U, Roopmani P, Krishnan U, Sethuraman S, Chauhan M, et al.
ACS Appl Mater Interfaces
. 2022 Nov;
14(48):54111-54126.
PMID: 36401830
The use of hydrogels as scaffolds for three-dimensional (3D) cell growth is an active area of research in tissue engineering. Herein, we report the self-assembly of an ultrashort peptide, a...
8.
Hou M, Barrett J, Themistocleous Y, Rawlinson T, Diouf A, Martinez F, et al.
medRxiv
. 2022 Jun;
PMID: 35664997
Background: There are no licensed vaccines against , the most common cause of malaria outside of Africa. Methods: We conducted two Phase I/IIa clinical trials to assess the safety, immunogenicity...
9.
Chibh S, Mishra J, Kour A, Chauhan V, Panda J
Nanomedicine (Lond)
. 2021 Jan;
16(2):139-163.
PMID: 33480272
Molecular self-assembly is a widespread natural phenomenon and has inspired several researchers to synthesize a compendium of nano/microstructures with widespread applications. Biomolecules like proteins, peptides and lipids are used as...
10.
Yadav N, Chauhan M, Chauhan V
Biomater Sci
. 2019 Nov;
8(1):84-100.
PMID: 31696870
Short peptides have attracted significant attention from researchers in the past few years due to their easy design, synthesis and characterization, diverse functionalisation possibilities, low cost, possibility to make a...